6CKX
Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)-N-((1r,4r)-4-(quinazolin-2-ylamino)cyclohexyl)acetamide
Summary for 6CKX
Entry DOI | 10.2210/pdb6ckx/pdb |
Descriptor | Cyclin-dependent kinase 12, Cyclin-K, MAGNESIUM ION, ... (5 entities in total) |
Functional Keywords | kinase, transferase, inhibitor, transferase-cell cycle-inhibitor complex, transferase-inhibitor complex, transferase/inhibitor |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 4 |
Total formula weight | 145342.32 |
Authors | Klein, M.G. (deposition date: 2018-03-01, release date: 2018-08-29, Last modification date: 2018-09-26) |
Primary citation | Ito, M.,Tanaka, T.,Toita, A.,Uchiyama, N.,Kokubo, H.,Morishita, N.,Klein, M.G.,Zou, H.,Murakami, M.,Kondo, M.,Sameshima, T.,Araki, S.,Endo, S.,Kawamoto, T.,Morin, G.B.,Aparicio, S.A.,Nakanishi, A.,Maezaki, H.,Imaeda, Y. Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. J. Med. Chem., 61:7710-7728, 2018 Cited by PubMed: 30067358DOI: 10.1021/acs.jmedchem.8b00683 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.8 Å) |
Structure validation
Download full validation report